EC blocks Illumina’s $7.1bn acquisition of diagnostic tests maker GRAIL
The European regulator found that the acquisition would provide Illumina with the ability and incentive to prevent GRAIL’s…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Sep 22
The European regulator found that the acquisition would provide Illumina with the ability and incentive to prevent GRAIL’s…
06 Sep 22
With more than 10,000 clinicians across all 50 states and a nationwide provider network of more than 50…
06 Sep 22
Galen is Ibex's integrated diagnostics platform supporting pathologists in the diagnosis of breast, prostate, and gastric biopsies
06 Sep 22
The approval was based on the TOPAZ-1 Phase III trial results, which demonstrated that a combination of Imfinzi…
06 Sep 22
Cue's molecular COVID-19 test, which is authorized by the FDA for home and POC use under an Emergency…
06 Sep 22
ProSense is an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus…
06 Sep 22
Devyser develops, produces, and sells genetic testing kits to laboratories in more than 45 countries
05 Sep 22
Whistleblower Laurie Simpson, a former Bayer employee who worked in the marketing division, claimed that the company breached…
02 Sep 22
New Hampshire accused J&J of promoting opioids to physicians and patients lying about how addictive they were when…
26 Aug 22
The approval was given by the Japanese Ministry of Health, Labour, and Welfare after assessing the findings of…